These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 32668617)
1. Interferon-Induced Transmembrane Protein 1 (IFITM1) Promotes Distant Metastasis of Small Cell Lung Cancer. Sakamoto S; Inoue H; Kohda Y; Ohba SI; Mizutani T; Kawada M Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668617 [TBL] [Abstract][Full Text] [Related]
2. New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice. Sakamoto S; Inoue H; Ohba S; Kohda Y; Usami I; Masuda T; Kawada M; Nomoto A Cancer Sci; 2015 Apr; 106(4):367-74. PubMed ID: 25640943 [TBL] [Abstract][Full Text] [Related]
3. Inhibiting of Proliferation, Migration, and Invasion in Lung Cancer Induced by Silencing Interferon-Induced Transmembrane Protein 1 (IFITM1). Yan J; Jiang Y; Lu J; Wu J; Zhang M Biomed Res Int; 2019; 2019():9085435. PubMed ID: 31205947 [TBL] [Abstract][Full Text] [Related]
4. Aberrant DNA methylation in the IFITM1 promoter enhances the metastatic phenotype in an intraperitoneal xenograft model of human ovarian cancer. Kim NH; Sung HY; Choi EN; Lyu D; Choi HJ; Ju W; Ahn JH Oncol Rep; 2014 May; 31(5):2139-46. PubMed ID: 24676393 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism. Lee J; Goh SH; Song N; Hwang JA; Nam S; Choi IJ; Shin A; Kim IH; Ju MH; Jeong JS; Lee YS Am J Pathol; 2012 Jul; 181(1):43-52. PubMed ID: 22609115 [TBL] [Abstract][Full Text] [Related]
6. MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo. Zhang F; Wang Y; Xu M; Dong H; Liu N; Zhou J; Pang H; Ma N; Zhang N; Pei Y; Zhang H; Liu L Oncol Rep; 2013 Jun; 29(6):2283-90. PubMed ID: 23588894 [TBL] [Abstract][Full Text] [Related]
7. The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies. Varker KA; Phelps SH; King MM; Williams CL Int J Oncol; 2003 Mar; 22(3):671-81. PubMed ID: 12579323 [TBL] [Abstract][Full Text] [Related]
8. KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer. Simó-Riudalbas L; Pérez-Salvia M; Setien F; Villanueva A; Moutinho C; Martínez-Cardús A; Moran S; Berdasco M; Gomez A; Vidal E; Soler M; Heyn H; Vaquero A; de la Torre C; Barceló-Batllori S; Vidal A; Roz L; Pastorino U; Szakszon K; Borck G; Moura CS; Carneiro F; Zondervan I; Savola S; Iwakawa R; Kohno T; Yokota J; Esteller M Cancer Res; 2015 Sep; 75(18):3936-45. PubMed ID: 26208904 [TBL] [Abstract][Full Text] [Related]
9. Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer. Sari IN; Yang YG; Phi LT; Kim H; Baek MJ; Jeong D; Kwon HY Oncotarget; 2016 Dec; 7(52):86039-86050. PubMed ID: 27852071 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells. Wang ZX; Lu BB; Yang JS; Wang KM; De W J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593 [TBL] [Abstract][Full Text] [Related]
11. Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer. Yang YG; Koh YW; Sari IN; Jun N; Lee S; Phi LTH; Kim KS; Wijaya YT; Lee SH; Baek MJ; Jeong D; Kwon HY Int J Cancer; 2019 Apr; 144(8):2020-2032. PubMed ID: 30318841 [TBL] [Abstract][Full Text] [Related]
12. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth. Perurena N; Zandueta C; Martínez-Canarias S; Moreno H; Vicent S; Almeida AS; Guruceaga E; Gomis RR; Santisteban M; Egeblad M; Hermida J; Lecanda F J Hematol Oncol; 2017 Jan; 10(1):23. PubMed ID: 28103946 [TBL] [Abstract][Full Text] [Related]
13. Combination of IFITM1 knockdown and radiotherapy inhibits the growth of oral cancer. Yang J; Li L; Xi Y; Sun R; Wang H; Ren Y; Zhao L; Wang X; Li X Cancer Sci; 2018 Oct; 109(10):3115-3128. PubMed ID: 29770536 [TBL] [Abstract][Full Text] [Related]
14. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814 [TBL] [Abstract][Full Text] [Related]
16. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional gene expression profiling of small cell lung cancer cells. Pedersen N; Mortensen S; Sørensen SB; Pedersen MW; Rieneck K; Bovin LF; Poulsen HS Cancer Res; 2003 Apr; 63(8):1943-53. PubMed ID: 12702587 [TBL] [Abstract][Full Text] [Related]
18. The role and mechanism of IFITM1 in developing acquired cisplatin resistance in small cell lung cancer. Wang X; Qian H; Yang L; Yan S; Wang H; Li X; Yang D Heliyon; 2024 May; 10(10):e30806. PubMed ID: 38803858 [TBL] [Abstract][Full Text] [Related]
19. Acquisition and enhanced expression of the metastatic phenotype following transfections of genomic mouse tumor DNA containing human SCLC gene sequences. Cate CC; Belloni DR; Marin-Padilla M Clin Exp Metastasis; 1995 May; 13(3):203-17. PubMed ID: 7750208 [TBL] [Abstract][Full Text] [Related]